Search clinical trials for: Cyclooxygenase 2 Inhibitors

Total 74751 results

Lawson Health Research Institute

Terminated

Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression

Postpartum Depression | Bipolar Disorder

Canada
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression

Osteoarthritis

France, Canada
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Study of Celecoxib Bioavailability in Healthy Subjects

Healthy Volunteers

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery

Arthroscopy

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis (SINCERE)

Arthritis, Juvenile Rheumatoid

United States
Rockefeller University

Completed

Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women

Obesity

United States
Hugh McMillan
Families of Spinal Muscular Atrophy; Gwendolyn Strong Foundation

Terminated

Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy (SMA)

Canada
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial

Memory Disorders

United States
Pfizer

Completed

A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan)

Osteoarthritis, Knee

Japan
Singapore General Hospital
Merck Sharp & Dohme LLC

Completed

Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty

Knee Osteoarthritis

Singapore
Sheba Medical Center

Unknown

Perioperative Use of a Selective COX2 Inhibitor in Patients Undergoing Elective Colorectal Surgery: the Effect on Post-operative Bowel Motility and Post-operative Pain

Prevention of Post Operative Ileus
Spanish Foundation of Rheumatology

Completed

Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs

Ankylosing Spondylitis

Spain
Xianwei Zhang
Pfizer

Completed

The Correlation of COX-2 Expression in Human Polymorphonuclear Leukocytes/Macrophages (PMNL/MP) and Postoperative Pain

Post-Operative Pain

China
Yonsei University

Completed

Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia

Biliary Atresia, Kasai Portoenterostomy Status
University of Regensburg
Merck Sharp & Dohme LLC

Completed

Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty

Coxarthrosis | Arthroplasties Hip Replacement | Perioperative Blood Loss

Germany
Barbro Dahlen
Karolinska Institutet

Completed

COX-2 Inhibition in Allergic Asthma

Asthma

Sweden
Ruhr University of Bochum

Terminated

Efficacy of Etoricoxib on Peripheral Hyperalgesia

Radiculopathy | Postherpetic Neuralgia | Causalgia | Peripheral Nerve Injury | Polyneuropathy

Germany
Walter Reed National Military Medical Center

Unknown

Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification

Ossification, Heterotopic

United States, Germany
Novartis

Completed

Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis

Osteoarthritis, Hip

United States, Canada, Germany, Italy, United Kingdom
Novartis

Completed

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA)

Osteoarthritis

United States, Canada
Novartis

Completed

Efficacy and Safety of Lumiracoxib

Osteoarthritis

Germany
University of Florida
Pfizer

Completed

Effect of Celecoxib on Markers of Vascular Inflammation

Hypertension and Coronary Artery Disease

United States
University Health Network, Toronto
Princess Margaret Hospital, Canada; Ontario Cancer Research Network

Completed

Celebrex With Preoperative Chemoradiation - Rectal Cancer

Colorectal Neoplasms

Canada
Maastricht Radiation Oncology
Pfizer

Completed

Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC

Non Small Cell Lung Carcinoma

Netherlands
University of Washington
Pfizer

Completed

Perioperative Inflammation and Cyclooxygenase 2 (COX-2)

Pain | Neurosurgery

United States
Pfizer

Completed

Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee

Osteoarthritis,Knee

Italy
Pfizer

Completed

A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain

Pain | Laparoscopic Cholecystectomy

United States
Tehran University of Medical Sciences
department of radiation oncology

Unknown

COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma

Head and Neck Cancer

Iran, Islamic Republic of
Medical University of Gdansk
Pharmacia; Central and Eastern European Oncology Group; Stowarzyszenie Ludzi...

Suspended

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

Non-Small Cell Lung Cancer

Poland
Organon and Co

Completed

Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)

Ankylosing Spondylitis
The University of Hong Kong

Completed

Treatment of Severe Influenza A Infection

Influenza, Human

Hong Kong
McGill University Health Centre/Research Institute...

Enrolling by invitation

Celebrex and HO Study

Heterotopic Ossification

Canada
University Hospitals Cleveland Medical Center
Pfizer

Completed

Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk

Knee Osteoarthritis

United States
Centre Oscar Lambret
Anticancer Fund, Belgium

Completed

Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas (FLUVABREX)

Glioma

France
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery

Arthroscopy

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen

Osteoarthritis, Knee

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen

Osteoarthritis, Knee

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain

Pain

Japan
Pfizer

Completed

Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee

Osteoarthritis of the Knee

China
Eli Lilly and Company

Completed

A Multiple Dose Study of LY3023703 in Healthy Participants

Healthy Volunteers

United States
M.D. Anderson Cancer Center

Terminated

Study of Vioxx and Radiation Therapy for Brainstem Glioma

Glioma | Brain Neoplasms

United States
Seoul National University Hospital

Completed

Impact of Celecoxib on Electrophysiological Property in Brain of Healthy Volunteer

Electrophysiologic Property of Brain

Korea, Republic of
University of Utah
Pfizer

Terminated

The Effects of Celecoxib on Bone Ingrowth

Pain | Bone Ingrowth

United States
Sun Yat-sen University

Completed

Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization

Hepatocellular Carcinoma
US Department of Veterans Affairs
University of California, Los Angeles; City of Hope Medical Center

Withdrawn

Celecoxib Treatment for Lung Cancer

Non-Small-Cell Lung Carcinoma

United States
Astellas Pharma Inc

Completed

Celecoxib Japan Observational Study for the Patients With Acute Pain

Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain

Japan
Boehringer Ingelheim

Completed

Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee

Osteoarthritis
Boehringer Ingelheim

Completed

A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee

Osteoarthritis
Tatyasaheb Kore Dental College

Completed

EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).

Periodontitis | Saliva | Cyclooxygenase Two Inhibitors | Etoricoxib | Superoxide Dismutase

India
University of Alabama at Birmingham
National Cancer Institute (NCI)

Withdrawn

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

Precancerous Condition

United States

Search clinical trials for: Cyclooxygenase 2 Inhibitors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations